Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Buffa

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
British Journal of Cancer|December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metforminSimon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 9, 2021
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiationRuben S A Goedegebuure, Esther A Kleibeuker, Francesca M Buffa, et al.
Cancer Cell|July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesisMassimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.
Elife|May 8, 2015
RIPOSTE: a framework for improving the design and analysis of laboratory-based researchNicholas Gd Masca, Elizabeth Ma Hensor, Victoria R Cornelius, et al.
The Journal of Clinical Investigation|July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoterAdèle Hannigan, Paul Smith, Gabriela Kalna, et al.
Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Ebiomedicine|May 7, 2018
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate CancerLingjian Yang, Darren Roberts, Mandeep Takhar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2018
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes ProjectPauline Robbe, Niko Popitsch, Samantha J L Knight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung CancerMichael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumErik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
British Journal of Cancer|December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metforminSimon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 9, 2021
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiationRuben S A Goedegebuure, Esther A Kleibeuker, Francesca M Buffa, et al.
Cancer Cell|July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesisMassimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.
Elife|May 8, 2015
RIPOSTE: a framework for improving the design and analysis of laboratory-based researchNicholas Gd Masca, Elizabeth Ma Hensor, Victoria R Cornelius, et al.
The Journal of Clinical Investigation|July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoterAdèle Hannigan, Paul Smith, Gabriela Kalna, et al.
Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Ebiomedicine|May 7, 2018
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate CancerLingjian Yang, Darren Roberts, Mandeep Takhar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2018
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes ProjectPauline Robbe, Niko Popitsch, Samantha J L Knight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung CancerMichael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumErik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Pageof 14